Genetic Variations of miRNAs and the Risk of Oral Squamous Cell Carcinoma: A Case-control Study
Aim:In this study, we investigated the association between two miRNA variants and the risk of oral squamous cell carcinoma (OSCC), and explored the interaction between clinical factors in the Turkish population.Methods:In this case control study, a total of 142 subjects were genotyped by polymerase...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2020-06-01
|
Series: | Haseki Tıp Bülteni |
Subjects: | |
Online Access: |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/genetic-variations-of-mirnas-and-the-risk-of-oral-/38673
|
Summary: | Aim:In this study, we investigated the association between two miRNA variants and the risk of oral squamous cell carcinoma (OSCC), and explored the interaction between clinical factors in the Turkish population.Methods:In this case control study, a total of 142 subjects were genotyped by polymerase chain reaction-restriction fragment length polymorphism to analyze miR-146aG/C (rs2910164) and miR-149C/T (rs2292832) variants. Associations between OSCC risk and clinicopathological characteristics were analyzed by chi-square test.Results:There was a significant difference in genotype and allele frequencies of miR-146aG/C variant between patients and control individuals. miR-146aG/C CC genotype and C allele were higher in the patient group compared to the control group (p=0.000, p=0.0001, respectively). Significant differences were also observed when the patients and the controls were compared according to CC vs GG+GC (p=0.0002) and GG vs GC+CC (p=0.002). In combined analysis, CC-CT combined genotype increased in patient group compared to controls (p=0.002), while GC-CT combined genotype increased in controls compared to patients (p=0.028).Conclusion:Our study provides evidence that miR-146aG/C variant may play an important role in susceptibility to OSCC in the Turkish population. |
---|---|
ISSN: | 1302-0072 2147-2688 |